Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Nordbyhagen, Norway Clinical Trials

A listing of Nordbyhagen, Norway clinical trials actively recruiting patients volunteers.

RESULTS

Found (13) clinical trials

Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid

In the clinical trial the investigators will assess efficacy, safety and tolerability after single and multiple doses of 3 millimolar 5 aminolevulinic acid (Gliolan) in combination with blue-light (405 nanometer) photopheresis in patients with active crohns disease. The study is a proof-of-concept pilot with 10 included patients where every patient …

Phase

0.06 miles

Learn More »

Nesiritide in Hypertension

Hypertension remains a global burden in cardiovascular disease leading to stroke, myocardial infarction, and heart failure. Its myocardial complications result from increased mechanical load on the heart. Under physiological conditions of increased myocardial load and resulting myocardial stretch, atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) synthesis and secretion …

Phase

0.95 miles

Learn More »

Investigation of Chronic Intestinal Ischemia

Patients With suspected chronic mesenteric ischemia (included truncus coeliacus compression syndrome) referred to vascular surgery department for investigation of splanchnic and mesenteric circulation shall inculded in this study. In addition to CT angiography patients shall be investigated With gastroscopy assisted laser Doppler flowmetry and spectrometry (GALS).

Phase

8.11 miles

Learn More »

"How do Contrast Medias in Bone Cement Affect DXA Measurements After THR"

Joint replacement is a well-documented and cost effective treatment of degenerative diseases in the hip (1,2). There are two different principles of fixation of prosthesis components; cemented and uncemented. The most common mode of fixation in Scandinavia has historically been with bone cement. In the recent years a reverse hybrid …

Phase

8.49 miles

Learn More »

Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)

Three parallel cohort, multicenter, open-label, phase I/II clinical trial to analyze the safety and feasibility of PD-1 inhibition with Nivolumab given concomitantly with standard radiotherapy regimens in the treatment of esophageal cancer. Cohort A: Advanced/inoperable esophageal cancer, eligible for palliative radiotherapy of the primary tumor. Cohort B: Inoperable esophageal cancer …

Phase

8.49 miles

Learn More »

Venetoclax Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma

Phase I/II trial, with the aim of evaluating the efficacy of venetoclax to the backbone of rituximab-lenalidomide in patients with relapsed/refractory MCL.

Phase

8.49 miles

Learn More »

Tocilizumab (RoActemra) and Tranexamic Acid (Cyklokapron) Used as Adjuncts to Chronic Subdural Hematoma Surgery

Primary endpoints in the study are: 1) determine postoperative recurrence requiring reoperation using clinical examination and CT imaging, 2) determine the time period necessary to complete healing using clinical examination and CT imaging. Secondary endpoints in the study are: 1) to determine the functional outcome and quality of life of …

Phase

8.49 miles

Learn More »

REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors

In this study, the aim is to release the brake on the immune response by use of nivolumab, an inhibitory antibody against Programmed cell death protein 1 (PD-1). Nivolumab has shown efficacy and mild toxicity when given as monotherapy for HNSCC at a dose of 3.0 mg/kg every 2 weeks, …

Phase

8.49 miles

Learn More »

Bortezomib and Temozolomide in Recurrent Glioblastoma With Unmethylated MGMT Promoter (BORTEM-17)

Patients harbouring tumours with functional O6 methylguanine DNA methyltransferase (MGMT) DNA repair enzyme efficiently repair the DNA damage inflicted by Temozolomide and gain limited benefit from this chemotherapy. Bortezomib depletes the MGMT enzyme, restoring the tumours susceptibility to Temozolomide, if the chemotherapy is administered in the precise schedule when the …

Phase

8.49 miles

Learn More »

Magnesium Replacement and Hyperglycemia After Kidney Transplantation

The insulin receptor is dependent on magnesium and hypomagnesemia is associated with increased insulin resistance and decreased insulin secretion and action. Recent data suggest that hypomagnesemia may play a role in development of type 2 diabetes. Kidney transplantation patients have low plasma magnesium levels, partly due to treatment with calcineurin …

Phase

8.49 miles

Learn More »